Best Life Sciences Platforms and Tools Companies in Georgia, United States
The 43 best Life Sciences Platforms and Tools companies in Georgia, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Arunabio.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Georgia
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Arunabio Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases 42Funding top 29%Talent bottom 49%Market bottom 47%Global bottom 37% All 5 signals ▾Fundingtop 29% Talentbottom 49% Marketbottom 47% Globalbottom 37% Newsbottom 18% Funding: Raised $33.1M across 20 rounds · 20 rounds over 9 yrs (2.2/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 42/100 | $33M | 12 mo ago | 40 | Steven Stice Co-Founder Chief Scientific Officer | — | — | — |
| 2 | Axion Biosystems Develops multi-electrode array technology to provide access to cellular information analysis | $20M | 79 mo ago | 14 | — | DrupalMariaDBPHP+24 | 43 patents Integrated electrophysiology‑optogenetics microelectrode arrays for high‑throughput cell culture assays | 1 internship · 1 launch |
| 3 | Lectenz Develops tools for biomarker discovery 35Innovation top 20%Funding top 44%Talent top 45%Product top 46% All 7 signals ▾Innovationtop 20% Fundingtop 44% Talenttop 45% Producttop 46% Techbottom 36% Globalbottom 29% Marketbottom 13% Innovation: 5 product lines Funding: Raised $15.3M across 12 rounds · 12 rounds over 17 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $15M | 10 mo ago | 6 | Robert Woods President | — | — | 1 partnership |
| 4 | Lucid Scientific Developer of real-time cell analysers | $13M | 35 mo ago | 7 | Walker Inman Founder | Cart FunctionalityContentfulThree.js+19 | — | 1 launch |
| 5 | Lena Biosciences Innovative 3D cell culture tools and services for drug discovery | $6M | 24 mo ago | 2 | Jelena Vukasinovic President and Founder | — | — | — |
| 6 | NatGlycan Manufacturer of natural glycans for research purpose | $5M | 16 mo ago | — | David Smith CEO | — | — | — |
| 7 | GlycoScientific Glycobiology research reagents, antibodies, and standards for glycosylation characterization | $4M | 38 mo ago | 6 | Ron Orlando Founder & CEO | Cart FunctionalityShopifyVisa+14 | 3 patents Stable isotope‑labeled glycan synthesis for mass‑spectrometry and analytical applications | — |
| 8 | Andson Biotech Provider of process analytical technologies for advanced biomanufacturing | $4M | 10 mo ago | 8 | Andrei Fedorov Co-Founder | — | — | 1 award |
| 9 | AKESOgen Provider of research services for scientists doing clinical and basic research | $2M | 88 mo ago | 1,526 1,526 → 3,055 (+100%) | Robert Boisjoli Co-Founder & CEO | — | — | 1 launch |
| 10 | OpenCell Technologies Develops transfection system | $798K | 172 mo ago | 4 | Andrei Fedorov Co-Founder & President | — | 15 patents Patents concentrated in electrical & electronics | — |
| 11 | Jeevan Biosciences Developer of human in vitro cell models for preclinical drug development in cancer | $767K | 180 mo ago | 9 | — | — | — | — |
| 12 | BiotecEra Synthetic biology for production of industrially valuable chemicals | $450K | 127 mo ago | — | Yuheng Lin Co-Founder & CTO | — | — | — |
| 13 | Sequegenics Provider of solutions for analyzing complex genetic datasets | $251K | 60 mo ago | 4 | Jorge Eloy Alan Atala Founder & Cto | — | — | — |
| 14 | Otogenetics Provider of the next-generation sequencing platform for genetic testing | $229K | 203 mo ago | 21 21 → 40 (+90%) | Aloma Geer CEO & MD | WordPressApple iCloud MailGoogle Workspace+13 | — | — |
| 15 | RayBiotech Develops antibody and protein array kits and reagents | $200K | 190 mo ago | 65 | — | WordPressMagentoCart Functionality+34 | 6 patents Immunoassay platforms for protein profiling and MRSA resistance antibody diagnostics | 2 launchs |
| 16 | CytoNest Manufacturer of 3D scaffolds | $175K | 37 mo ago | — | Nataraja Yadavalli Co-Founder & CEO | — | — | — |
| 17 | Renovo Pharmaceutical cocrystal and salt screening services for improved drug performance | $150K | 175 mo ago | — | — | — | 6 patents Patents concentrated in health & consumer products | — |
| 18 | Aptagen Provider and developer of aptamers antibodies for research application | $83K | 215 mo ago | 18 | — | WordPress Block EditorWordPressMySQL+16 | — | — |
| 19 | Immucor Provider of transfusion and transplantation diagnostic products | — | 73 mo ago | 44 | — | Microsoft SharePointApple iCloud MailMicrosoft 365+9 | 5 patents Blood testing reagents: red cell diluents with chelators and ADAMTS13 assay substrates. | — |
Top 12 Life Sciences Platforms and Tools companies in Georgia
#1
Series B · Athens, Georgia · founded 2003 · 40 employees$33.1Mraised▾
Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases. The platform develops neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders. The lead candidate drug AB126 is developed to treat stroke, Parkinson's, and multiple sclerosis
- Aug 2025Grant (prize money)$400K
- Jun 2022Grant (prize money)$679.4K
- Apr 2021Series B$10.8M
- Sep 2019Grant (prize money)$4.5M
#2
Funding Raised · Athens, Georgia · founded 2007 · 6 employees$15.3Mraised▾
Lectenz Biosis engaged in the discovery, detection, and analysis, of glycan biomarkers of significance. The company uses their proprietary technology for the discovery called Lectenz and GlycoSense technology platforms. Lectenz reagents are engineered from a carbohydrate-processing enzyme, forming a suite of the novel and highly specific reagents for glycan detection and/or enrichment and GlycoSense technology measures binding between glycans and glycan-specific reagents conjugated to multiplex microspheres using flow cytometry, These technologies enhance the glycoprofiling workflow.
- Sep 2025Grant (prize money)$2.3M
- Jul 2025Grant (prize money)$2M
- Jul 2025Grant (prize money)$313.8K
- Sep 2023Grant (prize money)$2M
#3
Series A · Atlanta, Georgia · founded 2021 · 8 employees$3.7Mraised▾
Provider of process analytical technologies for advanced biomanufacturing. The company's flagship product is DynaCHIP, drops into existing mass spectrometry workflows that enables sample preparation exponentially. It also offers DynaMARK, which incorporates a data science module to generate on-demand measurements of the most important metrics for modern biopharma workflows.
- Oct 2025Series A$5M
- 2025Grant (prize money)—
- Mar 2024Series A$3.6M
- Mar 2022Seed$500K
#4
Funding Raised · Atlanta, Georgia · founded 2017$4.9Mraised▾
NatGlycan manufactures natural glycans for research purposes. The proprietary process is based on controlled oxidation using sodium hypochlorite (household bleach). Most natural glycans occur as glycoconjugates, in which glycans are attached to other biomolecules such as proteins or lipids. The products provided are animal organs, plants or plant derivatives purified glycans and glycan derivatives in vials or as glycan microarrays.
- Apr 2025Grant (prize money)$1.9M
- Sep 2022Grant (prize money)$315K
- Apr 2019Grant (prize money)$2.2M
- Mar 2019Grant (prize money)$289.3K
#5
Funding Raised · Atlanta, Georgia · founded 2008 · 2 employees$5.7Mraised▾
Innovative 3D cell culture tools and services for drug discovery. The company engineers fit-for-purpose 3D tissue models and assays for drug discovery and predictive toxicology. Their mission is to revolutionize in vitro research and expedite the discovery of safer and more effective medicines. They provide innovative 3D cell culture products and services for biomedical research and drug development. The offerings include perfused organ panels, 3D cell culture scaffolds, and 3D cell invasion assays. Services encompass liver toxicity and mitochondrial toxicity assessments. These tools and services aim to provide human-relevant data for the development of safe and effective medicines, essentially running clinical trials in a dish. The technology recreates the physiological architecture that cells experience in vivo, offering advanced, 3D tissue models and high-sensitivity, mechanistic assays for safety and efficacy evaluations of drugs, chemicals, and biologics.
- Aug 2024Grant (prize money)$900.8K
- Jun 2022Grant (prize money)$299.9K
- Aug 2020Grant (prize money)$2.1M
- May 2016Grant (prize money)$1.4M
#6
Series A · Atlanta, Georgia · founded 2012 · 7 employees$13.4Mraised▾
Lucid Scientific is a developer of real-time cell analyzers. The RESIPHER consists of 96-well plastic lids with an on-plate monitor which is used to record the incubator data. It monitors continuous, non-invasive oxygen consumption rate to provide analytical data. The company also offers cell hand-held culture monitors.
- Sep 2023Series A$9.2M
- Sep 2020Seed$3.6M
#7
Funding Raised · Athens, Georgia · founded 2009 · 6 employees$4.4Mraised▾
Glycobiology research reagents, antibodies, and standards for glycosylation characterization. The company develops and commercializes unique research reagents in glycobiology, focusing on glycosylation characterization. Their expertise lies in proteomics, glycomics, liquid chromatography, and mass spectrometry of glycans and glycoproteins. They develop antibodies for quantitation of specific glycan modifications on proteins involved in human diseases like cancer, diabetes, and neurodegenerative disorders. They offer custom antibody development services, leveraging a unique technology platform to overcome hurdles in glycoprotein-specific antibody creation. Their products include antibodies to O-GlcNAc and O-Fucose, IgG/Glycoprotein Quantitation Standards, and Histone Reagents. They also offer Guinea Pig and Golden Hamster Reagents. The website features a shop with a cart, login, and account creation options. Payment options include American Express, Mastercard, PayPal, Visa, and others.
- Jun 2023Grant (prize money)$275.8K
- Sep 2020Grant (prize money)$252.1K
- May 2019Grant (prize money)$298.5K
- Sep 2016Grant (prize money)$242.3K
#8
Acquired · Atlanta, Georgia · founded 2007 · 14 employees$20.3Mraised▾
Axion BioSystems develops multi-electrode array technology to provide access to cellular information analysis for research, clinical, and drug discovery markets. It offers single-well systems, stimulating and recording channels, channel systems, multi-well systems, and integrated circuits for the elimination of stimulation artifacts.
- Jan 2020Grant (prize money)$2.8M
- Sep 2018Series C$8M
- May 2016Series C$6M
- Apr 2016Grant (prize money)$220K
#9
Funding Raised · Athens, Georgia · founded 2020$175Kraised▾
Manufacturer of 3D scaffolds. It caters to cell culture technology research for tissue engineering, cultured meat, cultured seafood, and regenerative medicine applications.
- Jul 2023Grant (prize money)$175K
#10
Seed · Norcross, Georgia · founded 2010 · 1526 employees$1.5Mraised▾
Provider of research services for scientists doing clinical and basic research. It provides biomarker profiling, cytogenomic arrays, sequencing (NGS and Sanger), genotyping, and epigenomic by analyzing different types of markers (like DNA, mRNA, miRNA, and methylation) and biobanking. It is certified by CLIA and CAP.
- Apr 2019Seed$1.5M
#11
Funding Raised · Atlanta, Georgia · founded 2008 · 4 employees$798Kraised▾
OpenCell Technologies has developed a new electromechanical method of transfection. The technology is called Electrosonic Actuation Microarray. It(STEAM -Single-sample Treatment via Electrosonic Actuation Microarray) uses microscopic nozzles to eject cells. The nozzles have electroporation electrodes, which perform cell poration(mechanical and electrical disruption of the membrane) during ejection.
- Apr 2012Grant (prize money)$518.7K
- Jun 2010Grant (prize money)$158.7K
- Feb 2009Grant (prize money)$120.6K
#12
Deadpooled · Atlanta, Georgia · founded 2007 · 9 employees$767.2Kraised▾
Developer of human in vitro cell models for preclinical drug development in cancer. The company's platform is claimed to do the following; (i) provide pure human cancer stem cell models that accurately represent cancer tissue, (ii) provide a media that allows human cell tissue to be cultured in an environment free of animal and other non-human products, and (iii) identify unique biomarkers in cancer stem cells that can be accurately and consistently targeted by a drug delivery platform.
- Aug 2011Grant (prize money)$383.6K
- Jul 2011Grant (prize money)$383.6K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Georgia is moving
A read on the academic research around Bioinformatics in Georgia — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 161 papers.
- Georgia Institute of Technology88
- University of Georgia40
- Georgia State University19
- Georgia Southern University4
- Georgia College & State University3
- Gene1→7
- Genome3→5
- Gene2→3
- Immune system1→4
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.